Leif Gunnar Håkansson
Chief Executive Officer at CanImGuide Therapeutics AB
Leif Gunnar Håkansson active positions
| Companies | Position | Start | End |
|---|---|---|---|
CanImGuide Therapeutics AB
 CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Director/Board Member | - | - |
| Chief Executive Officer | - | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
| Founder | - | - |
Career history of Leif Gunnar Håkansson
Former positions of Leif Gunnar Håkansson
| Companies | Position | Start | End |
|---|---|---|---|
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Training of Leif Gunnar Håkansson
| University of Lund | Doctorate Degree |
Statistics
International
| Sweden | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 1 |
|---|---|
CanImGuide Therapeutics AB
CanImGuide Therapeutics AB Pharmaceuticals: MajorHealth Technology CanImGuide Therapeutics AB develops cancer therapies. The firm is a biotechnological company that reverses cancer related immunosuppression. It manufactures the proprietary drug P28R, a peptide with two modes of actions. The company was founded on March 21, 2006 and is headquartered in Hollviken, Sweden. | Health Technology |
